MedTrace Logo

Comparative Study of Augmented Reality vs Traditional Learning in Anatomy Education

NCT05985746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2023-08-14

No results posted yet for this study

Summary

The goal of this clinical trial is to assess the efficacy of augmented reality (AR) in anatomy teaching.

The main question to answer is: Is 3-Dimensional AR technology more effective than traditional learning methods in anatomy education? In this clinical trial undergraduate medical students with no prior anatomy education will be recruited. Participants in the AR group will learn the anatomy of the cranial nerves with an AR application using Microsoft HoloLens 2, whereas participants in the control group will learn with traditional learning methods (textbooks, atlases, videos, and online learning programs).

Conditions

  • Augmented Reality
  • Anatomy Education

Interventions

OTHER

Augmented reality group

* Study presentation: participants will be given a 10-minute general introduction on the study followed by a 20 minutes tutorial to introduce the HoloLens 2 and the TEACHANATOMY learning platform. * Study session: The study session consists of three learning blocks of approximately 20 minutes each, plus a repetition block to assess the acquired knowledge. During the study session participants will be given no time constraints and free breaks. * Assessment test: Participants will be assessed with a 30 minutes knowledge assessment test. * Final questionnaire: At the end participants will be given a questionnaire to assess adverse health symptoms and user experience.

OTHER

Traditional learning group

* Study presentation: participants will be given a 10-minute general introduction on the study followed by a presentation to introduce the study session. * Study session: The study session consists of the learning resources most used by students: specific sections from four different neuroanatomy books, access to two websites, two 3D videos, and two online learning programs. During the study session participants will be given no time constraints and free breaks. * Assessment test: Participants will be assessed with a 30 minutes knowledge assessment test. * Final questionnaire: At the end participants will be given a questionnaire to assess adverse health symptoms and user experience.

Sponsors & Collaborators

  • University of Zurich

    collaborator OTHER

  • Balgrist University Hospital

    lead OTHER

Principal Investigators

  • Lukas Zingg, Cand. Med. · Balgrust University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-21
Primary Completion
2022-10-24
Completion
2022-10-24

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05985746 on ClinicalTrials.gov